Cervical spine disorders are becoming increasingly common, particularly among sedentary populations. The accurate segmentation of cervical vertebrae is critical for diagnostic and research applications. Traditional segmentation methods are limited in terms of precision and applicability across imaging modalities. The aim of this study is to develop and evaluate a fully automatic segmentation method and a user-friendly tool for detecting cervical vertebral body using a combined neural network model based on the YOLOv11 and U-Net3 + models. A dataset of X-ray and magnetic resonance imaging (MRI) images was collected, enhanced, and annotated to include 2136 X-ray images and 2184 MRI images. The proposed YOLO-UNet ensemble model was trained and compared with four other groups of image extraction models, including YOLOv11, DeepLabV3+, U-Net3 + for direct image segmentation, and the YOLO-DeepLab network. The evaluation metrics included the Dice coefficient, Hausdorff distance, intersection over union, positive predictive value, and sensitivity. The YOLO-UNet model combined the advantages of the YOLO and U-Net models and demonstrated excellent vertebral body segmentation capabilities on both X-ray and MRI datasets, which were closer to the ground truth images. Compared with other models, it achieved greater accuracy and a more accurate depiction of the vertebral body shape, demonstrated better versatility, and exhibited superior performance across all evaluation indicators. The YOLO-UNet network model provided a robust and versatile solution for cervical vertebral body segmentation, demonstrating excellent accuracy and adaptability across imaging modalities on both X-ray and MRI datasets. The accompanying user-friendly tool enhanced usability, making it accessible to both clinical and research users. In this study, the challenge of large-scale medical annotation tasks was addressed, thereby reducing project costs and supporting advancements in medical information technology and clinical research.

The use of artificial intelligence (AI) in medicine has shown promise to improve the quality of healthcare decisions. However, AI can be biased in a manner that produces unfair predictions for certain demographic subgroups. In MIMIC-CXR, a publicly available dataset of over 300,000 chest X-ray images, diagnostic AI has been shown to have a higher false negative rate for racial minorities. We evaluated the capacity of synthetic data augmentation, oversampling, and demographic-based corrections to enhance the fairness of AI predictions. We show that adjusting unfair predictions for demographic attributes, such as race, is ineffective at improving fairness or predictive performance. However, using oversampling and synthetic data augmentation to modify disease prevalence reduced such disparities by 74.7% and 10.6%, respectively. Moreover, such fairness gains were accomplished without reduction in performance (95% CI AUC: [0.816, 0.820] versus [0.810, 0.819] versus [0.817, 0.821] for baseline, oversampling, and augmentation, respectively).

Machine learning (ML) algorithms play a crucial role in the early and accurate diagnosis of Alzheimer's Disease (AD), which is essential for effective treatment planning. However, existing methods are not well-suited for identifying Mild Cognitive Impairment (MCI), a critical transitional stage between normal aging and AD. This inadequacy is primarily due to label imbalance and bias from different sensitve attributes in MCI classification. To overcome these challenges, we have designed an end-to-end fairness-aware approach for label-imbalanced classification, tailored specifically for neuroimaging data. This method, built on the recently developed FACIMS framework, integrates into STREAMLINE, an automated ML environment. We evaluated our approach against nine other ML algorithms and found that it achieves comparable balanced accuracy to other methods while prioritizing fairness in classifications with five different sensitive attributes. This analysis contributes to the development of equitable and reliable ML diagnostics for MCI detection.

Artificial intelligence (AI) shows promise in clinical tasks, yet its integration into workflows remains underexplored. This study proposes an AI-aided same-day diagnostic imaging workup to reduce recall rates following abnormal screening mammograms and alleviate patient anxiety while waiting for the diagnostic examinations. Using discrete simulation, we found minimal disruption to the workflow (a 4% reduction in daily patient volume or a 2% increase in operating time) under specific conditions: operation from 9 am to 12 pm with all radiologists managing all patient types (screenings, diagnostics, and biopsies). Costs specific to the AI-aided same-day diagnostic workup include AI software expenses and potential losses from unused pre-reserved slots for same-day diagnostic workups. These simulation findings can inform the implementation of an AI-aided same-day diagnostic workup, with future research focusing on its potential benefits, including improved patient satisfaction, reduced anxiety, lower recall rates, and shorter time to cancer diagnoses and treatment.